T
Tomasz Kosmalski
Researcher at Nicolaus Copernicus University in Toruń
Publications - 22
Citations - 147
Tomasz Kosmalski is an academic researcher from Nicolaus Copernicus University in Toruń. The author has contributed to research in topics: Chemistry & Oxime. The author has an hindex of 4, co-authored 18 publications receiving 58 citations.
Papers
More filters
Journal ArticleDOI
Latest developments in metal complexes as anticancer agents
Renata Paprocka,Małgorzata Wiese-Szadkowska,Sabina Janciauskiene,Sabina Janciauskiene,Tomasz Kosmalski,Marcelina Kulik,Anna Helmin-Basa +6 more
TL;DR: A review of metal-based cancer drug candidates can be found in this paper, where the benefits and drawbacks regarding the activity and toxicity of the metalbased cancer drugs candidates are discussed.
Journal ArticleDOI
Asymmetric synthesis of β-dialkylamino alcohols by transfer hydrogenation of α-dialkylamino ketones
TL;DR: In this article, transfer hydrogenation of representative aryl and heteroaryl dialkylaminomethyl ketones with formic acid-triethylamine, catalyzed by RuCl[(R,R)-TsDPEN]-η-p-cymene, produces the corresponding β-dialkylamino alcohols, 97-99% ee, in 50-73% yields.
Journal ArticleDOI
The Evaluation of Vitiligous lesions Repigmentation after the Administration of Atorvastatin calcium salt and Simvastatin-acid sodium salt in patients with active vitiligo (EVRAAS), a pilot study: study protocol for a randomized controlled trial.
Anna Niezgoda,Andrzej Winnicki,Tomasz Kosmalski,Bogna Kowaliszyn,Jerzy Krysiński,Rafał Czajkowski +5 more
TL;DR: This study is the first to evaluate safety and efficacy of the topical use of statins in patients presenting with nonsegmental vitiligo (NSV), and it is shown that statins act through several immunological pathways, potentially reversing undesirable phenomena underlying autoimmune Vitiligo pathogenesis.
Journal ArticleDOI
A novel derivatives of thiazol-4(5H)-one and their activity in the inhibition of 11β-hydroxysteroid dehydrogenase type 1.
TL;DR: The synthesis of 2-(allylamino)thiazol-4(5H)-one derivatives by the reaction of N-allylthiourea with appropriate α-bromoesters is presented, which appears to be promising and should be subjected to further testing.
Journal ArticleDOI
Thiazolo[3,2-a]pyrimidin-5-one derivatives as a novel class of 11β-hydroxysteroid dehydrogenase inhibitors
Renata Studzińska,Daria Kupczyk,Anita Plazinska,Renata Kołodziejska,Tomasz Kosmalski,Bożena Modzelewska-Banachiewicz +5 more
TL;DR: The most active compound only in the slight degree inhibits 11β-HSD2 activity and is a selective inhibitor of 11 β-hydroxysteroid dehydrogenase type 1, which can have a real effect on the regulation of the cortisol level in the body.